Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Carter Eric G Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 Carter Eric G (Director) has filed a Form 4 on AEON Biopharma, Inc.
Txns: Granted 58,851 options @ $5.47, valued at $321.9k
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
06/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2019 4 Carter Eric G (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 45,000 options to buy @ $13.41, valued at $603.5k
06/15/2018 4 Carter Eric G (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 35,000 options to buy @ $6.25, valued at $218.8k
04/25/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
09/08/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/08/2017 3 Carter Eric G (Director) has filed a Form 3 on Adverum Biotechnologies, Inc.
03/01/2011 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
02/02/2011 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns: Unknown transaction of 135,427 shares @ $0
Disposed/sold 38,740 shares @ $0
Disposed/sold 55,740 options to buy @ $0
Disposed/sold 17,860 options to buy @ $0
Disposed of 34,240 options to buy @ $8.91, valued at $305.1k
Disposed of 50,290 options to buy @ $6.97, valued at $350.5k
Disposed of 42,240 options to buy @ $12.44, valued at $525.5k
01/20/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
01/20/2011 4/A Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns: Granted 16,260 shares @ $0
Granted 16,260 shares @ $0
01/11/2011 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns: Granted 16,260 shares @ $0
12/01/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
03/31/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
03/24/2010 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,772 shares @ $12.25, valued at $21.7k
03/19/2010 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns: Granted 11,970 shares @ $0
Granted 42,240 options to buy @ $12.44, valued at $525.5k
03/01/2010 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns: Granted 55,740 options to buy @ $0
01/26/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
01/05/2010 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns: Exercised 12,698 options to buy @ $0
03/25/2009 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
03/12/2009 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
02/19/2009 4 Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
01/22/2009 4/A Form 4/A -- Statement of changes in beneficial ownership of securities [amend]
01/21/2009 4 Form 4 -- Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy